Bosh sahifaRGEDF • OTCMKTS
add
Gedeon Rixter
Yopilish kursi
27,17 $
Yillik diapazon
24,01 $ - 29,58 $
Narx/foyda
-
Dividend daromadliligi
-
Bozor yangiliklari
.INX
0,95%
0,99%
1,12%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(HUF) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 216,73 mlrd | 14,95% |
Joriy xarajat | 94,69 mlrd | 10,59% |
Sof foyda | 37,06 mlrd | -32,07% |
Sof foyda marjasi | 17,10 | -40,89% |
Har bir ulushga tushum | — | — |
EBITDA | 76,39 mlrd | 23,89% |
Amaldagi soliq stavkasi | 19,13% | — |
Balans
Jami aktivlari
Jami passivlari
(HUF) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 74,99 mlrd | -29,24% |
Jami aktivlari | 1,49 trln | 9,53% |
Jami passivlari | 258,83 mlrd | -1,37% |
Umumiy kapital | 1,23 trln | — |
Tarqatilgan aksiyalar | 182,62 mln | — |
Narxi/balansdagi bahosi | 0,00 | — |
Aktivlardan daromad | 10,29% | — |
Kapitaldan daromad | 11,59% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(HUF) | sen, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 37,06 mlrd | -32,07% |
Operatsiyalardan naqd pul | 67,55 mlrd | 56,30% |
Sarmoyadan naqd pul | -13,69 mlrd | 54,12% |
Moliyadan naqd pul | -36,70 mlrd | -409,23% |
Naqd pulning sof oʻzgarishi | 17,12 mlrd | -34,71% |
Boʻsh pul | 13,19 mlrd | 1 594,12% |
Haqida
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
CEO
Tashkil etilgan
1901
Xodimlar soni
11 603